Cardiopulmonary Exercise Testing Market Segmentation by End-User (Clinics & Hospitals, Ambulatory Centers, and Diagnostic Centers); and by Product Type (Stress Blood Pressure Monitors, Exercise Testing Systems, Pulse Oximeters, and Others)-Global Demand Analysis & Opportunity Outlook 2031
-
Product Code:
RP-ID-10077079 -
Published Date:
27 Oct 2022 -
Region:
Global
-
Category:
Healthcare & Pharmaceuticals -
Publisher:
Pub-ID-54
Impact Analysis on the Growth of Market
Inflation and Looming Recession to Haunt Businesses:
In 2022 & 2023, market players expected to sail in rough waters; might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain. Further, U.S. economy is expected to grow merely by 3% in 2022.
....
The Research Report is Updated with 2022 Base Year, 2023 Estimated year and Forecast till 2035 with Market Insights.
With the dip in global production, the GDP has contracted in 2020 and impacted the market across the world. Upon placing a Sample Request, you will receive an updated report with 2022 as base year, 2023 as estimated year and forecast to 2035. This will have market drivers, recovery rate in the market, insights and competitive analysis.
Market Overview:
Translate Report
Global Cardiopulmonary Exercise Testing Market Highlights Over 2022- 2031
The global cardiopulmonary exercise testing market is estimated to grow at a ~5% CAGR over the forecast period, i.e., 2022–2031. Moreover, the market registered a revenue of approximately USD 3.0 billion in 2021. The growth of the market can be attributed to the surge in the volume of subsidies provided by the government of nations for the advancement of healthcare infrastructure and the rise in research and development activities for developing cardiovascular exercise testing devices to detect the disease at an earlier stage. Moreover, an increase in the number of heart disease cases across the globe is anticipated to drive the growth of the market. As per the World Health Organization, approximately 17.9 million people died in 2019 from cardiovascular disease which accounted to 32 percent of global deaths.
GET A SAMPLE COPY OF THIS REPORT
The global cardiopulmonary exercise testing market is segmented by end-user into clinics & hospitals, ambulatory centers, and diagnostic centers. Out of these, the clinics & hospitals segment is anticipated to hold the largest share by the end of 2031 owing to the rise in the number of patients arriving for treatment in the hospital and its high financial capability to keep updated technology for the diagnosis of the patient.
Global Cardiopulmonary Exercise Testing Market Regional Synopsis
Regionally, the global cardiopulmonary exercise testing market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in the North America region is estimated to witness noteworthy growth over the forecast period on the back of an increase in the number of heart disease cases, and rising awareness among people related to the cardiopulmonary exercise testing system for diagnosis of the disease. According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the U.S and accounts for a death of a person in every 36 seconds.
Market Segmentation
Our in-depth analysis of the global cardiopulmonary exercise testing market includes the following segments:
By End-User
-
Clinics & Hospitals
-
Ambulatory Centers
-
Diagnostic Centers
By Product Type
-
Stress Blood Pressure Monitors
-
Exercise Testing Systems
-
Pulse Oximeters
-
Others
Growth Drivers and Challenges Impacting the Growth of the Global Cardiopulmonary Exercise Testing Market
Growth Drivers
-
Increasing R&D Activities for the Development of Advanced Cardiopulmonary Exercise Testing Products
-
Growing Number of Heart Disease Cases Across the Globe
Challenges
-
High Cost of the Cardiopulmonary Exercise Testing Devices
-
Lack of Skilled Workers for Operating these Devices
Key Companies Dominating the Global Cardiopulmonary Exercise Testing Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global cardiopulmonary exercise testing market that are included in our report are NIHON KOHDEN CORPORATION, MGC Diagnostics Corporation, VYAIRE MEDICAL, INC., Koninklijke Philips N.V., Schiller Americas, Inc., General Electric Company, COSMED srl, Therma Fisher Scientific, Halma plc, Masimo, and others.
Latest Developments in the Global Cardiopulmonary Exercise Testing Market:
- 21 December 2021 – General Electric Company announced the acquisition of BK Medical from Altaris Capital Partners, LLC has been completed. The companies agreed to a definitive agreement in which GE will buy BK Medical for USD 1.45 billion in cash.
- 8 December 2021: Thermo Fisher Scientific Inc., announced the completion of its USD 17.4 billion acquisition of PPD, Inc. in order to expand their value proposition for biotech and pharmaceutical customers.
Key Reasons to Buy Our Report
- The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
- It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
- The report includes detailed company profiles of the major players dominating the market.
- We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
- We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
Geography Analysis:
The report further discusses the market opportunity, compound annual growth rate (CAGR) growth rate, competition, new technology innovations, market players analysis, government guidelines, export and import (EXIM) analysis, historical revenues, future forecasts etc. in the following regions and/or countries:
- North America (U.S. & Canada) Market Size, Y-O-Y Growth, Market Players Analysis & Opportunity Outlook
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC(Finland, Sweden, Norway, Denmark), Ireland, Switzerland, Austria, Poland, Turkey, Russia, Rest of Europe), Poland, Turkey, Russia, Rest of Europe) Market Size, Y-O-Y Growth Market Players Analys & Opportunity Outlook
- Asia-Pacific (China, India, Japan, South Korea, Singapore, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market Size, Y-O-Y Growth & Market Players Analysis & Opportunity Outlook
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market Size, Y-O-Y Growth Market Players Analysis & Opportunity Outlook
.
FREQUENTLY ASKED QUESTIONS
Increasing R&D activities for the development of advanced cardiopulmonary exercise testing products and an increase in the number of heart diseases cases across the globe are the major factors driving the growth of the cardiopulmonary exercise testing market.
The market is anticipated to attain a CAGR of ~5% over the forecast period, i.e., 2022-2031.
High cost of the cardiopulmonary exercise testing systems and lack of skilled workers for operating the systems are estimated to hamper the market growth.
North America region will provide more business opportunities for growth of cardiopulmonary exercise testing market in future.
The major players in the market are NIHON KOHDEN CORPORATION, MGC Diagnostics Corporation, VYAIRE MEDICAL, INC., Koninklijke Philips N.V., Schiller Americas, Inc., General Electric Company, COSMED srl, Therma Fisher Scientific, Halma plc, Masimo, and others.
The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
The global cardiopulmonary exercise testing market is segmented by product type, end-user, and by region.
The clinics & hospitals segment is anticipated to hold largest share over the forecast period and display significant growth opportunities.
Please enter your personal details below
- NIHON KOHDEN CORPORATION
- MGC Diagnostics Corporation
- VYAIRE MEDICAL INC.
- Koninklijke Philips N.V.
- Schiller Americas Inc.
- General Electric Company
- COSMED srl
- Therma Fisher Scientific
- Halma plc
- Masimo